Novartis AG (NEO:NVS)

Market Cap	293.40B
Revenue (ttm)	74.42B
Net Income (ttm)	17.18B
Shares Out	n/a
EPS (ttm)	8.45
PE Ratio	17.08
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	747
Average Volume	555
Open	21.68
Previous Close	21.43
Day's Range	21.68 - 21.68
52-Week Range	20.11 - 24.03
Beta	n/a
RSI	47.54
Earnings Date	Apr 29, 2025

About Novartis AG

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Re...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Cboe Canada
• Ticker Symbol: NVS

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD